FDA Takes Aim At Reducing Health Disparities Through Breakthrough Devices Program

Proposed updates to the US FDA’s breakthrough devices program guidance would help to clarify how the program may be applicable to devices that treat and diagnose diseases that disproportionately affect certain populations.